Buscar
Mostrando ítems 61-70 de 937
Short communication: β-Lactam resistance and vancomycin heteroresistance in Staphylococcus spp. isolated from bovine subclinical mastitis
(2017-08-01)
The use of antimicrobial agents has led to the emergence of resistant bacterial strains over a relatively short period. Furthermore, Staphylococcus spp. can produce β-lactamase, which explains the survival of these strains ...
Novel Strategies for the Management of Vancomycin-Resistant Enterococcal Infections
(2019)
Purpose of Review Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens that commonly affect critically ill patients. VRE have a remarkable genetic plasticity allowing them to acquire genes associated ...
Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin America
(2020-06)
Background: Vancomycin is a common first-line option for MRSA infections. The heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) phenotype is associated with therapeutic failure. However, hVISAisolates are ...
The use of vancomycin with its therapeutic and adverse effects: a review
(Verduci Publisher, 2015-01-01)
OBJECTIVE: Vancomycin (VCM) is a tricyclic glycopeptide antibiotic produced by Streptococcus orientalis. Widely used in hospitals, it is indicated to fight severe infections caused by Gram-positive bacteria, especially ...
The rise of the Enterococcus: Beyond vancomycin resistance
(Springer NatureNature reviews microbiology, 2012)